Related Experiment Videos

[Malignant pertussis and exchange transfusion]

J Chantreuil1, N Fakhri2, F Labarthe3

  • 1Réanimation pédiatrique et néonatologie, hôpital Clocheville, CHRU de Tours, 49, boulevard Béranger, 37000 Tours, France.

Insights

Malignant pertussis is a severe condition with high mortality. Exchange transfusion effectively reduced extreme leukocytosis in an infant, improving outcomes before hemodynamic collapse.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Malignant pertussis presents as a severe clinical state with high fatality rates (70%).
  • Key severity criteria include lung infection, pulmonary hypertension, and extreme leukocytosis (typically >50 G/L).

Observation:

  • A 2.5-month-old infant with malignant pertussis developed acute respiratory distress syndrome and pulmonary hypertension.
  • A secondary Enterobacter cloacae infection complicated the clinical course, requiring high-frequency oscillatory ventilation and pulmonary vasodilatation therapy.
  • Despite initial management, the infant's hyperleukocytosis reached 70 G/L.

Findings:

  • Exchange transfusion was performed on day 9 to address severe hyperleukocytosis.
  • The procedure successfully reduced leukocyte count to below 40 G/L.
  • Following exchange transfusion, the infant showed steady improvement in pulmonary function, enabling weaning from mechanical ventilation and eventual discharge.

Implications:

  • Exchange transfusion is a viable therapeutic option for infants with malignant pertussis and extreme leukocytosis.
  • Considering exchange transfusion before hemodynamic failure may improve survival prognosis in these critical cases.
Abstract

Related Concept Videos